0.59 mg fluocinolone acetonide intravitreal implant
420-003
Phase 2 small_molecule completed
Quick answer
0.59 mg fluocinolone acetonide intravitreal implant for Diabetic Macular Edema is a Phase 2 program (small_molecule) at Bausch & Lomb Incorporated with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bausch & Lomb Incorporated
- Indication
- Diabetic Macular Edema
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed